Status:
UNKNOWN
Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae
Lead Sponsor:
Ain Shams University
Conditions:
Effect of Meperidine or Drotaverine on Effacement and Dilatation of the Cervix During Labor in Full Term Primigravidae
Eligibility:
MALE
Phase:
PHASE2
Brief Summary
Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae
Detailed Description
Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae Protocol of Thesis Submitted for partial fulfillment of maste...
Eligibility Criteria
Inclusion
- ● primigravida.
- Singleton pregnancy.
- Term gestation i.e, 38-41 weeks.
- Sure, reliable dates documented by ultrasound in the 1st half of pregnancy.
- Vertex presentation with occipito anterior position.
- Efficient uterine contractions at a rate of at least 3 to 4 contractions every 10 minutes, each contraction lasting for at least 40 seconds.
Exclusion
- ● Abnormal presentation or occipito posterior position.
- Multiple pregnancies.
- Cephalo-pelvic disproportion.
- Cervical surgery in the past or history of cervical injury.
- Patients on antihypertensive therapy.
- Known hypersensitivity to drotaverine or meperidine.
- If any other spasmolytic agent had been used within 48 hours.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01236651
Start Date
November 1 2010
End Date
September 1 2011
Last Update
November 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud
Cairo, Egypt